| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 5,631.0 | 5,289.0 |
| Net income | 1,219.0 | 579.0 |
| EPS (diluted, $ a share) | $12.41 | $3.86 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +110.5% |
|---|---|
| Revenue, year on year | +6.5% |
| Operating margin | 31.1% |
10-Q filed with the SEC, NYSE: THC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Tenet Healthcare Corp: key numbers
- Share price
- $291.54Close, Nov 16
- Market cap
- $23.2B
- Shares outstanding
- 79.59MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-General Medical & Surgical Hospitals, NECSIC 8062
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Tenet Healthcare Corp
All →Tenet Healthcare Director Roy Blunt Sells $293K of Stock
Roy Blunt, Director, sold 1,000 shares of Tenet Healthcare Corp at $293.00 a share, worth $293K in total on Nov 11, 2026. Shares held after the trade: 3,589 (-21.8%).
- Value
- $293K
- Shares
- 1,000
- Price
- $293.00
- Role
- Director
- Holding change
- -21.8%
- Trade date
- Nov 11, 2026
Tenet Healthcare Financial Results
Tenet Healthcare reported strong Q3 2026 results with net operating revenues of $5.63 billion and Adjusted EBITDA of $1.36 billion, driven by same-store revenue growth and expense management. The company raised its full-year 2026 Adjusted EBITDA outlook to a range of $5.05 billion to $5.20 billion.
- Term
- Q3 2026
“Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management. Our focus on patient-centered care, support for physician partners, technology-enabled growth and operating initiatives continue to deliver strong margins and free cash flow.”
Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet
Tenet Healthcare $2B Debt Financing with The Bank of New York Mellon Trust Company, N.A.
Tenet Healthcare Corporation issued $2.0 billion in 6.250% senior notes due 2034. The company intends to use the proceeds to redeem $1.5 billion of its 5.125% senior secured first lien notes due 2027 and $0.5 billion of its 6.125% senior notes due 2028.
- Value
- $2B
- Counterparty
- The Bank of New York Mellon Trust Company, N.A.
- Term
- through 2034
Tenet Healthcare Director J. Robert Kerrey Sells $3.17M of Stock
J. Robert Kerrey, Director, sold 12,010 shares of Tenet Healthcare Corp at $263.04 to $264.62 a share (average $263.72) in 3 transactions, worth $3.17M in total on Sep 14, 2026. Shares held after the trade: 4,794 (-34.3%).
- Value
- $3.17M
- Shares
- 12,010
- Average price
- $263.72
- Role
- Director
- Holding change
- -34.3%
- Trade date
- Sep 14, 2026